MMP9 and cystic fibrosis: During acute pulmonary exacerbations in CF, oral doxycycline administration led to a significant 63.2% reduction in total sputum MMP-9 levels, along with improvements in forced expiratory volume in one second and a prolonged exacerbation-free interval (15).